Theravance Biopharma Receives FDA Fast Track Designation for TD-8954 for Use With Enteral Feeding in Critically Ill Patients
Go back to Theravance Biopharma Receives FDA Fast Track Designation for TD-8954 for Use With Enteral Feeding in Critically Ill Patients| (NASDAQ: TBPH) | Delayed: 17.06 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $17.06 | 52 Week High | $38.92 | |||
| Open | $17.06 | 52 Week Low | $12.87 | |||
| Day High | $17.06 | P/E | N/A | |||
| Day Low | $17.06 | EPS | $0.00 | |||
| Volume | 3 | |||||
